Cargando…
Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication
Domperidone is an antagonist of the peripheral dopamine (D2) receptor. It works as an antiemetic by blocking D2-receptors at the chemoreceptor trigger zone and as a gastroprokinetic drug by blocking GI tract D2-receptors. According to research, using domperidone significantly raises the risk of card...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289668/ https://www.ncbi.nlm.nih.gov/pubmed/37363600 http://dx.doi.org/10.1097/MS9.0000000000000723 |
_version_ | 1785062328924897280 |
---|---|
author | Kalwar, Asifa Mangi, Rabel Q. Rehman, Junaid U. Ochani, Sidhant Faraz, Muhammad Kukreja, Sandhaya Hasibuzzaman, Md. Al |
author_facet | Kalwar, Asifa Mangi, Rabel Q. Rehman, Junaid U. Ochani, Sidhant Faraz, Muhammad Kukreja, Sandhaya Hasibuzzaman, Md. Al |
author_sort | Kalwar, Asifa |
collection | PubMed |
description | Domperidone is an antagonist of the peripheral dopamine (D2) receptor. It works as an antiemetic by blocking D2-receptors at the chemoreceptor trigger zone and as a gastroprokinetic drug by blocking GI tract D2-receptors. According to research, using domperidone significantly raises the risk of cardiac arrhythmia and sudden cardiac death by 70%, most likely through prolonging the QT interval. Blockade of hERG voltage-gated potassium channels is thought to be the reason. Here in Pakistan, this drug is being prescribed by every other physician and even patients frequently self-medicate themselves with it. Due to the serious side effects of this medication, extreme caution should be exercised when prescribing it, especially to the elderly, those who have underlying QT prolongation, those taking medications known to prolong QT, and even more so in pregnant women as there is some evidence that domperidone crosses into breast milk in small amounts and causes an irregular heartbeat in the baby. At least we, on our part, can limit the usage of the drug only with a prescription and, where necessary, if not completely, stop it. |
format | Online Article Text |
id | pubmed-10289668 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-102896682023-06-24 Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication Kalwar, Asifa Mangi, Rabel Q. Rehman, Junaid U. Ochani, Sidhant Faraz, Muhammad Kukreja, Sandhaya Hasibuzzaman, Md. Al Ann Med Surg (Lond) Short Communications Domperidone is an antagonist of the peripheral dopamine (D2) receptor. It works as an antiemetic by blocking D2-receptors at the chemoreceptor trigger zone and as a gastroprokinetic drug by blocking GI tract D2-receptors. According to research, using domperidone significantly raises the risk of cardiac arrhythmia and sudden cardiac death by 70%, most likely through prolonging the QT interval. Blockade of hERG voltage-gated potassium channels is thought to be the reason. Here in Pakistan, this drug is being prescribed by every other physician and even patients frequently self-medicate themselves with it. Due to the serious side effects of this medication, extreme caution should be exercised when prescribing it, especially to the elderly, those who have underlying QT prolongation, those taking medications known to prolong QT, and even more so in pregnant women as there is some evidence that domperidone crosses into breast milk in small amounts and causes an irregular heartbeat in the baby. At least we, on our part, can limit the usage of the drug only with a prescription and, where necessary, if not completely, stop it. Lippincott Williams & Wilkins 2023-04-27 /pmc/articles/PMC10289668/ /pubmed/37363600 http://dx.doi.org/10.1097/MS9.0000000000000723 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Short Communications Kalwar, Asifa Mangi, Rabel Q. Rehman, Junaid U. Ochani, Sidhant Faraz, Muhammad Kukreja, Sandhaya Hasibuzzaman, Md. Al Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication |
title | Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication |
title_full | Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication |
title_fullStr | Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication |
title_full_unstemmed | Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication |
title_short | Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication |
title_sort | lack of knowledge regarding the misuse of domperidone in pakistan and its serious consequences: short communication |
topic | Short Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289668/ https://www.ncbi.nlm.nih.gov/pubmed/37363600 http://dx.doi.org/10.1097/MS9.0000000000000723 |
work_keys_str_mv | AT kalwarasifa lackofknowledgeregardingthemisuseofdomperidoneinpakistananditsseriousconsequencesshortcommunication AT mangirabelq lackofknowledgeregardingthemisuseofdomperidoneinpakistananditsseriousconsequencesshortcommunication AT rehmanjunaidu lackofknowledgeregardingthemisuseofdomperidoneinpakistananditsseriousconsequencesshortcommunication AT ochanisidhant lackofknowledgeregardingthemisuseofdomperidoneinpakistananditsseriousconsequencesshortcommunication AT farazmuhammad lackofknowledgeregardingthemisuseofdomperidoneinpakistananditsseriousconsequencesshortcommunication AT kukrejasandhaya lackofknowledgeregardingthemisuseofdomperidoneinpakistananditsseriousconsequencesshortcommunication AT hasibuzzamanmdal lackofknowledgeregardingthemisuseofdomperidoneinpakistananditsseriousconsequencesshortcommunication |